• 5hmC remodeling is widespread during human CD4 + T-cell differentiation • Early 5hmC gains predict loss of DNA methylation in differentiated cells • 5hmC remodeling in vitro predicts loss of DNA methylation in vivo • 5hmC loci are enriched for functional, T-cell disease associated genetic variants eTOC Nestor, Lentini and colleagues reveal widespread 5hmC-mediated DNA de-methylation during in vitro differentiation of human CD4 + T-cells and propose 5hmC profiling as a novel and effective approach for the identification of regulatory variants in human disease.
Summary
Conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) by TET enzymes is critical to DNA methylation reprogramming. Mutation of TET genes in T-cell malignancies and loss of TET activity resulting in auto-immune phenotypes in mouse, suggests important roles in T-cell biology. Consistent with this, we report early and widespread 5mC/5hmC remodeling during human CD4 + T-cell differentiation ex vivo at genes and cell-specific enhancers with known T-cell function. We observed similar DNA de-methylation in CD4 + memory T-cells in vivo, indicating that early remodeling events persist in differentiated cells.
Underscoring their important function, 5hmC loci were highly enriched for genetic variants associated with T-cell diseases and T-cell-specific chromosomal interactions. Extensive functional validation of 22 risk variants revealed novel, potentially pathogenic, mechanisms in diabetes and multiple sclerosis. Our results support 5hmC-mediated DNA de-methylation as a key component of CD4 + T-cell biology in humans, with important implications for identifying disease-associated genetic variants.
INTRODUCTION
Differentiation of CD4 + T-cells into effector or regulatory subtypes is critical to adaptive immunity. Upon contact with antigens, T-cells differentiate into various T-helper (Th) cell subsets, such as Th1, Th2, Th17 or regulatory T (Treg) cells (Yamane and Paul, 2013) , which mediate or inhibit immune responses. Inappropriate CD4 + T-cell differentiation is associated with several autoimmune and inflammatory diseases, including rheumatoid arthritis (RA), psoriasis, allergy, asthma, multiple sclerosis (MS) and type 1 diabetes (Gustafsson et al., 2015; Licona-Limon et al., 2013; Wahren-Herlenius and Dorner, 2013) . The lack of a strong genetic component and increasing prevalence of these diseases suggests an epigenetic contribution to their pathogenesis, and changes in T-cell DNA methylation patterns have been reported in MS, allergy, and RA (Graves et al., 2013; Liu et al., 2013; Nestor et al., 2014a) .
Appropriate differentiation of Th subsets requires widespread remodeling of the T-cell epigenome, including DNA de-methylation of many master regulators of the differentiation process, such as Il4, Il5, Il13 (Th2) , Ifng (Th1) and FOXP3 (Treg) (Janson et al., 2011; Lee et al., 2006) . 5-hydroxymethylcytosine (5hmC) was recently discovered to be highly abundant in the human genome and generated by hydroxylation of 5-methylcytosine (5mC) by members of the Ten-Eleven-Translocation (TET1/2/3) family of enzymes (Tahiliani et al., 2009). 5hmC can subsequently be resolved to unmodified cytosine, completing the process of DNA demethylation ( Figure S1A) . Significantly, TET loss-of-function mutations have been identified in several hematological malignancies, with the highest frequency in adult CD4 + T-cell cancers (Kalender Atak et al., 2012; Lemonnier et al., 2012) . Moreover, Tet2 knockout mice exhibit impaired differentiation of hematopoietic stem cells and developed autoimmune phenotypes (Ichiyama et al., 2015; Ko et al., 2011; Li et al., 2011; Yang et al., 2015) . Despite the valuable insights into the role of TET-5hmC during differentiation of mammalian CD4 + Tcells obtained from mouse models (Ichiyama et al., 2015; Ko et al., 2011; Tsagaratou et al., 2014; Yang et al., 2015) , little is known about the importance of DNA de-methylation in human CD4 + T-cell differentiation and its contribution to the pathogenesis of complex immune diseases.
We generated genome-wide maps of 5hmC, 5mC and gene expression during early and late stages of human CD4 + T-cell differentiation ex vivo. Changes in 5hmC were widespread during both activation and differentiation of CD4 + T-cells, occurred at a variety of activating and repressive regulatory elements, and coincided with tight regulation of TET gene expression.
Significantly, all early 5hmC and 5mC remodeling occurred in the complete absence of replication, suggesting an 'active', enzymatic remodeling mechanism. Using genetic overexpression we showed that tight regulation of TET levels was required for appropriate expression of key lineage specific transcription factors and cytokines. We confirmed these findings in vivo by transcriptional and epigenetic profiling of human naïve CD4 + T cells (NT), central memory (TCM) and effector memory T-cells (TEM). Supporting the disease relevance of 5hmC-mediated DNA de-methylation, loci gaining 5hmC during early T-cell differentiation were highly enriched for variants associated with T-cell related diseases at a diversity of cisand trans-gene regulatory elements. Moreover, these regions were also enriched for T-cell specific chromosomal interactions, supporting their importance in T-cell biology. We undertook further functional characterization of the effects of over 20 predicted regulatory variants on the level of DNA-protein interactions, and reveal novel, potentially pathogenic, mechanisms in diabetes and multiple sclerosis. Our results support 5hmC-mediated DNA demethylation as a key component of CD4 + T-cell biology in humans, and 5hmC profiling as a novel and cost-effective approach for identification of regulatory genetic variants in complex immune disease.
RESULTS

5hmC remodeling during CD4 + T-cell differentiation occurs in absence of replication and is enriched at key regulatory genes
To dissect the role of DNA de-methylation in human CD4 + T cell function, we took advantage of the ability to differentiate pure human naïve T-cells into T helper cell subsets in vitro ( Figure   1A ). This powerful approach allowed direct observation of the early 5hmC remodeling events, occurring in the absence of DNA replication, that result in the stable lineage-specific 5mC profiles observed in differentiated T helper cell subsets. Appropriate differentiation into Th1 and Th2 lineages was confirmed by gene expression microarray and qRT-PCR of key lineagespecific genes (Figures S1B-C & Table S1 ). In vitro polarization of NT cells resulted in a >5fold loss (PT-TEST < 0.05) of global 5hmC levels ( Figure 1B) . A small, but consistent 10-15% loss of global 5hmC levels was also observed after only 1 day of in vitro polarization, consistent with changes in the 5-hydroxymethylome occurring before the onset of DNA replication (Figures 1B & S1D-E). Next, we combined 5hmC DNA immuno-precipitation with massively parallel sequencing (hMeDIP-seq) to generate the first hydroxymethylomes of human CD4 + Tcells differentiating into Th1 and Th2 effector cells in two replicate experiments. 5hmC profiles were generated in naïve cells and both at early (1 day) and late (5 day) time-points during polarization, allowing identification of both early replication-independent changes as well as later subset-specific changes in 5hmC. We generated 1 billion paired reads in total and for each condition 35-60 million paired reads were uniquely mapped to the human genome (hg19) ( Table S2 ). 5hmC showed characteristic enrichment in gene bodies and depletion at transcription start sites as previously reported in other cell types ( Figure 1C ) and a clear association with actively transcribed genes ( Figure 1D ) (Nestor et al., 2012; Song et al., 2011) .
Similar to results reported in mouse CD4 + T-cells, the distribution of 5hmC enrichment was significantly overrepresented in genic regions in all T-cell subsets ( Figure 1E & Table S2 ) (Ichiyama et al., 2015; Tsagaratou et al., 2014) .
To understand the biological relevance of these changes, we mapped the 1,000 largest gains and losses of 5hmC to their nearest gene and subjected these to gene ontology (GO) enrichment analysis. Strikingly, whereas regions losing 5hmC were not enriched in any biological processes, regions gaining 5hmC at day 1 in either Th1 or Th2 cells were highly significantly (PADJUSTED < 1 x 10 -8 ) enriched for genes associated with T-cell activation ( Figure   1F and data not shown), including the signature genes IFNG, TBX21, FOXP3, ZAP70, IL2RA, IL7R, IRF4, CD5, AIM2, CCR2, CCR5, IL1R2, IL26 and IL32R (Figure 1G and data not shown). Globally, large-scale remodeling of 5hmC had occurred by day 1, with over 10,000 and 5,000 regions significantly gaining or losing 5hmC, respectively ( Figure S1F and Table   S2 ). The scale of change was far greater in regions gaining 5hmC ( Figure S1G) .
Taken together, these results reveal genome-wide, replication-independent reprogramming of 5hmC during CD4 + T-cell differentiation at genes key to appropriate T-cell activation and differentiation.
Lineage specification of human CD4 + T-cells is preceded by 5hmC-mediated DNA demethylation of gene regulatory elements
To relate 5hmC remodeling during differentiation to changes in DNA methylation (5mC), we subjected the same in vitro differentiated human Th1 and Th2 cells to DNA methylation profiling using Infinium 450K methylation arrays. Although not genome-wide, these arrays provide quantitative, base-resolution methylation measurements at ~450,000 CpG sites throughout the genome, allowing accurate detection of even small (> 3%) changes in absolute methylation levels. We observed a clear bias towards loss of 5mC in both Th1 and Th2 differentiated cells with more pronounced changes occurring by day 5 (Figure 2A) . However, some changes in DNA methylation were also observed at day one (123 CpGs >10% loss, P < 0.05), in complete absence of replication (Figures S2A & Table S3 ) suggesting that such changes are active, and not secondary to DNA replication. Importantly, regions gaining 5hmC at day one of differentiation in both Th1 and Th2 cells were highly significantly enriched for CpGs losing 5mC at day 5 (P < 0.0001, Fisher exact test) ( Figures 2B & S2B ), suggesting that DNA de-methylation at these loci occurs primarily via a 5hmC-mediated process. Indeed, loci showing the greatest loss of 5mC during Th1 and Th2 differentiation were also those showing the greatest gains in 5hmC after only 1 day of polarization ( Figure 2C) . Finally, genes showing loss of DNA methylation (> 30% loss of 5mC) in their promoters during differentiation were enriched for functional terms related to the immune response ( Figure S2C ), further indicating that DNA de-methylation occurs in a targeted manner. Taken together, these findings suggest a model whereby loci to be de-methylated in differentiated T-cell subtypes first undergo enzymatic hydroxylation of 5mC to 5hmC followed by both replication-independent excision and replication-dependent dilution of 5hmC during successive rounds of DNA replication.
As the majority (> 95%) of loci undergoing 5hmC remodeling during early CD4 + Tcell differentiation occurred outside annotated gene promoters, we hypothesized that these loci might represent gene regulatory elements. Indeed the TET enzymes interact with numerous chromatin modifiers (HDAC1, HDAC2, EZH2, SIN3A) and co-repressor complexes (NuRD) which may serve to target TET methylcytosine dioxygenase activity to regulatory elements within the genome (Delatte et al., 2014) and elevated 5hmC levels have been observed at active enhancers in several systems (Lu et al., 2014; Tsagaratou et al., 2014) . Using published chromatin-immunoprecipitation (ChIP)-sequencing data, we analyzed the association between 5mC/5hmC remodeling in CD4 + T-cells and the enhancer-associated histone modifications, H3K4me1 and H3K27ac (Hawkins et al., 2013) (Figure 2D) . Indeed, Th1-and Th2-specific active enhancer elements marked by H3K27ac (Hawkins et al., 2013) were highly enriched for regions showing 5mC loss during differentiation (~15-fold, p < 0.001) (Figures 2E-G) .
Ectopic expression of TET1 results in dysregulation of key cytokine and chemokine genes during differentiation
Expression profiling by qPCR showed that TET1, in contrast to TET2 and TET3, was highly expressed in T-cells, as well as thymus compared to other human tissues and immune cells ( Figure 3A & Figure S3A ). Moreover, whereas the absolute levels of TET1 were lower than those of TET2 and TET3 during T-cell differentiation, TET1 alone underwent, rapid and stable down-regulation during early T-cell activation (>10-fold reduction; P < 0.01, t-test) (Figures Figure S3B ). Indeed, TET1 silencing was observed as early as 6 hours after initiation of differentiation ( Figure S3B) . Unlike Tet2 and Tet3, Tet1 has been shown to bind to Polycomb target gene promoters and associate with chromatin repressors, thereby having a role in direct transcriptional repression unrelated to its enzymatic activity (Williams et al., 2011; Wu et al., 2011) . Thus, we sought to dissect the functional role of TET1 during early T-cell differentiation by ectopic expression of full-length human TET1 (TET1fl) (Tahiliani et al., 2009 ), the catalytic domain of TET1 (TET1cd) or a mutated catalytic domain of TET1 (TET1mut) lacking enzymatic activity (Guo et al., 2011) (Figures 3D and S3C-D) . Notably, overexpression of TET1fl led to significant dysregulation of chemokine and cytokine gene mRNA levels (log2FC >0.5), including several key regulators of Th1/Th2 differentiation, including IFNG, IL12RB2, HAVCR2, GATA3 and IL5. (Figures 3E and S3E ). Far fewer changes in gene expression were observed with TET1cd ( Figures 3F and S3F, Table S4 ), the majority of which were associated with calcium ion channel activity ( Figure S3F) . These findings suggests that TET1 might act as a direct transcriptional repressor during T-cell differentiation. However, as the transcriptional programs of each T helper subset generally inhibit those of the other lineages future studies are warranted to fully elucidate the functional role of TET1. Nevertheless, the results clearly support an important role for TET1 in the regulation of key genes during lineage-specification of T-helper cell subsets.
3B-3C &
5hmC remodeling during early differentiation of human CD4 + T-cells predicts loss of 5mC in CD4 + memory T-cells in vivo.
We and other have previously shown that adaptation of primary mammalian cells to culture can affect the genomic distribution of 5hmC (Nestor et al., 2012; Nestor et al., 2015) . Thus, having determined the DNA methylation dynamics of human T-cell differentiation in vitro, we sought to establish if similar changes occurred in vivo. After activation and differentiation of naïve T-cells (NT), a small proportion of cells remain as long-lived memory cell populations, which can be sub-divided into central memory (TCM) and effector memory (TEM) subsets based on their function and homing capacity (Sallusto et al., 2004) . We isolated primary human NT (CD4 + CD45RO -CCR7 + ), TCM (CD4 + CD45RO + CCR7 + ) and TEM (CD4 + CD45RO + CCR7 -) cells by FACS (purity >95%) for analysis ( Figure S4A) . Consistent with our findings in polarized T-cells, in vivo memory subsets exhibited decreased (P < 0.05, t-test) levels of TET1 and TET3 (Figure 4A ) as well as lower global 5hmC content (Figure 4B) , verifying that TET inactivation events observed during polarization also occur in vivo. Next, we generated gene expression and genome-wide DNA methylation profiles for NT, TCM and TEM cells. Gene expression of TCM and TEM cells showed distinct profiles, with TEM cells expressing high levels of effector molecules such as IL4, IFNG and CSF2, while TCM cells showed an intermediate Interestingly, DNA methylation profiles could clearly separate NT, TCM and TEM cells indicating that each subset is epigenetically distinct (Figure 4D & S4D) . Furthermore, TEM cells showed extensive genome-wide de-methylation, exceeding that of TCM (Figure 4E) , consistent with the notion that TEM cells are more terminally differentiated. As expected, DNA methylation changes in gene promoters was correlated with gene expression (rho = -0.43, p = 5.9e-08) ( Figure 4F) . Having characterized methylome-and transcriptome dynamics in memory T-cells, we sought to relate these changes to early hydroxymethylome reprogramming during T-cell polarization. Consistent with our findings in polarized T-cells, regions gaining 5hmC after one day of polarization exhibited extensive de-methylation in memory cells (P = 6.20e-78, Fisher's exact test) (Figure 4G-I) . As 5hmC and 5mC cannot be distinguished by conventional bisulfite conversion (Nestor et al., 2014b) , we performed 5hmC/5mC-specific qPCR for selected loci undergoing 5mC changes in NT, TCM and TEM cells (Figure S4E-F ,   Table S6 ).
Thus, early methylome-reprogramming events initiated by 5hmC are maintained longterm in memory T-cells in vivo.
5hmC remodeling marks regulatory regions enriched for disease-associated genetic variants
Consistent with previous reports in other cell types (Wu and Zhang, 2014) , 5hmC in CD4 + Tcells marked several different types of gene regulatory elements (such as enhancers, promoters and gene bodies). Using a Hidden Markov model together with published genome-wide data sets for several epigenetic marks in primary human NT cells (Bernstein et al., 2010; Chen, 2015) ( Table S7 ) we observed that 5hmC occupied a unique position in the genome, associating with both repressive and activating states, supporting the property of 5hmC as a general marker of gene regulatory activity (Figure 5A ). Since the majority of diseaseassociated variants are found in non-coding regions, we compared the frequency of all diseaseassociated variants reported at the time of analysis (NleadVariant = 73, 196 ; P < 1x10 -5 , GWASdb2) (Li et al., 2012) and those in high LD (NVARIANT = 600,320, r 2 > 0.8, 1000 Genomes Project, phase 3) in regions gaining or losing 5hmC at day 1 of in vitro polarization, resulting in a total of 1,560 variants (Table S8) . Regions gaining 5hmC (hereafter referred to as "5hmC regions") were significantly enriched (P < 0.01) for disease associated variants in 19 diseases, where six out of the top ten diseases were autoimmune whereas regions losing 5hmC showed no significant enrichment for CD4 + T-cell diseases (Figure 5B) . Strikingly, regions gaining 5hmC were twice as likely (OR 2.6, p < 0.0001; Fisher's exact test) to overlap a disease-associated variant than cell type-specific enhancers (Figure 5C) (Hawkins et al., 2013) . 5hmC has previously been associated with transcription factor binding sites (TFBS) (Yu et al., 2012) suggesting that variants in 5hmC regions may modulate gene expression by disrupting TF binding. We tested all 1,560 5hmC variants using phylogenetic module complexity analysis (PMCA), leveraging the conservation of co-occurring transcription factor binding site (TFBS) patterns within gene regulatory modules, as previously described by us (Claussnitzer et al., 2014) . Interestingly, for the variants in 5hmC regions we found 49.4% predicted to be regulatory compared to our previous findings of 33.3% in a random set of variants (Claussnitzer et al., 2014) (Table S8) . To experimentally evaluate the effects of identified non-coding variants on regulatory protein binding we performed electrophoretic mobility-shift assays (EMSAs) using nuclear protein extracts from both transformed and primary, trait-related human CD4 + T-cells, using probes for the risk and non-risk alleles of 22 variants (44 alleles) ( Table S9 ). First, we tested variants associated with Crohn's disease and multiple sclerosis, as these diseases showed the highest enrichment for variants in 5hmC Table S8 ). We also tested variants associated with non-enriched T-cell associated diseases (such as allergy) and other non T-cell associated traits (obesity, metabolite levels) with high TFBS module conservation ( Figure 5B & Table S8 ). We found an allelespecific shift in 16 out of 22 tested variants when using protein extracts from the Jurkat T-cell line (Figure 5D & Figure S5A ), supporting that 5hmC can aid in the identification of regulatory variants, potentially contributing to disease pathophysiology. Importantly, variantinduced alterations on regulator binding could be replicated by using nuclear protein from primary human CD4 + T-cells isolated from healthy individuals ( Figure 5E ).
As none of the risk variants affecting regulator binding were located within gene promoters or gene coding regions, we assessed how risk variants might modulate gene expression via physical interaction with distal gene regulatory elements. Using chromatin interaction data (capture Hi-C; cHi-C) for a human CD4 + T-cell line (Martin et al., 2015) we found that disease-associated variants located in 5hmC regions were significantly enriched (PBOOTSTRAP < 1x10 -4 ) for long-range chromatin interactions compared to all disease-associated variants (Figure 5F) . Interestingly, enrichment of chromatin interactions for disease-associated variants in 5hmC regions was greater than that observed for T-cell specific enhancers (Hawkins et al., 2013 ) even though, not surprisingly, enhancer regions alone had a significantly higher number of chromatin interactions compared to 5hmC regions (Figure 5F and data not shown). These findings strongly support the power of 5hmC as a precise and efficient marker to identify regulatory disease-associated variants.
To further validate our approach we examined interactions at the CLEC16A locus, which is associated with several autoimmune diseases (Wellcome Trust Case Control, 2007) ( Figure 5G) . Out of 30 variants in high LD (r 2 >0.8), five were located in 5hmC regions, two of which were significantly enriched for TFBS module conservation (Table S8 ). For these two variants, we observed differential protein binding for rs7203150 in both Jurkat and primary human CD4 + cells (Figure 5D and E, P = 5.9 x 10 -7 / 1.8 x 10 -3 , respectively, Student's t test), whereas no allele specific binding was observed for rs7198004 (Table S8, Figure S5A ). The variant rs7203150 is located in intron 19 of the CLEC16A gene, containing many variants associated with multiple autoimmune diseases and has been shown to physically interact with and regulate the expression of a neighboring gene, DEXI (Davison et al., 2012) . Capture Hi-C data confirmed the highly significant interaction of the rs7203150 region with the DEXI promoter (FDR<5%), as expected, but also revealed a novel interaction with a downstream gene, RMI2 (Figure 5G) . In fact, cHi-C data suggest interactions for numerous genes at the CLEC16A locus, SOCS1,a negative regulator of cytokine signaling (Diehl et al., 2000) , DEXI, a gene of unknown function but proposed as autoimmune candidate gene (Leikfoss et al., 2013) , RMI2, a topoisomerase critical for T-cell differentiation and a primary immunodeficiency syndrome candidate gene (Monnich et al., 2010) , to CLEC16A, recently shown to affect T-cell selection, mediate T1D and modify CD4 single positive thymocyte reactivity (Schuster et al., 2015) (Figure 5G) . Finally, in our T-cell data we find supportive coexpression of CLEC16A with CIITA, SOCS1, DEXI and RMI2 (Figure 5G, right panel) .
Thus, 5hmC remodeling marks cell-type specific, gene regulatory regions, which may contribute to pathogenic mechanisms in CD4 + T-cell associated diseases.
DISCUSSION
Previous studies of 5hmC during T-cell differentiation have reported global loss of 5hmC in differentiated T helper subsets in mouse (Ichiyama et al., 2015; Tsagaratou et al., 2014; Yang et al., 2015) . We confirm these findings, but using a time-series profiling approach, we also report widespread 5hmC remodeling during early differentiation, including >10,000 locusspecific gains of 5hmC enriched at genes associated with T-cell function. Here, we report that 5hmC-mediated DNA de-methylation is a key feature of human CD4 + T-cell differentiation and that tight regulation of TET gene expression is critical for appropriate differentiation of Thelper subsets. These DNA de-methylation events were also observed in memory T-cells in vivo and were enriched for variants associated with CD4 + T-cell diseases including multiple sclerosis, psoriasis and Crohn's disease. Several disease-associated variants affected DNAprotein interactions in primary human CD4 + T-cells and reveal novel, potentially pathogenic mechanisms in several autoimmune diseases. To our knowledge this is the first time demethylation events have been used to trace disease-associated variants in a trait-related cell type. As 5hmC profiling can be performed on small amounts (> 25 ng) of archived, fragmented genomic DNA it is ideal for identifying and stratifying potential regulatory variants in rare primary cell types (Taiwo et al., 2012) . This is in contrast to chromatin-based enhancerprofiling strategies which typically requires profiling of multiple epigenetic marks in large amounts of fresh material (Hawkins et al., 2013) .
Studies in mouse have provided valuable insights into the role of DNA methylation
during differentiation of mammalian CD4 + T-cells, but less is known about the importance of DNA de-methylation in human CD4 + T-cell differentiation and its contribution to the pathogenesis of complex immune diseases (Ichiyama et al., 2015; Ko et al., 2011; Tsagaratou et al., 2014; Yang et al., 2015) . Our profiling of the methylome (5mC), hydroxymethylome (Ichiyama et al., 2015; Ko et al., 2010; Tsagaratou et al., 2014; Yang et al., 2015) .
In addition to direct differentiation into effector subtypes, a proportion of activated NT cells become long-lived and retain 'memory' of the initial activating signal (Sallusto et al., 1999) . Methylome profiling of NT, TCM and TEM cells ex vivo, revealed that the DNA methylation changes observed early during differentiation persist in memory T-cells. First, this important observation supports the validity of in vitro CD4 + T-cell differentiation as a powerful model system in which to study the epigenetics of human CD4 + T-cells. Second, these data suggest that any dysregulation of the DNA de-methylation pathway will not only affect immediate response to antigen (differentiation), but also appropriate formation of T-cell memory.
The availability of global profiles for several activating and repressive epigenetic marks allowed us to study the epigenetic neighborhood occupied by 5hmC in human CD4 + T-cells. We used a recently described Hidden Markov model based approach to identify the distinct chromatin states present in human naïve CD4 + T-cells (Song and Chen, 2015) . Interestingly, instead of simply following the patterning of 5-methylcytosine, from which it is derived, 5hmC was present in chromatin states composed of activating, repressive and poised histone modifications (Figure 5A) . 5hmC's presence across so many chromatin states may reflect its property as an intermediate during conversion of transcriptionally repressive 5-methylcytosine to transcriptionally permissive unmodified cytosine (Hon et al., 2014) . Alternatively, 5hmC's association with such a diverse range of histone marks may reflect the growing realization of the TET enzymes as multi-faceted proteins, connecting different layers of epigenetic and transcription control to maintain cell state (Laird et al., 2013) . Indeed, the TET enzymes have been reported to directly interact with transcriptional activators including PU.1, EBF1 and p300, while also interacting with proteins associated with transcriptional repression, including EZH2, SIN3A, HDACs, NuRD and MeCP2 (Cartron et al., 2013; Delatte et al., 2014) .
Regardless of the underlying mechanism, 5hmC's position as a general but sensitive indicator of chromatin state make it a powerful tool in the identification of cell-type specific regulatory elements. Indeed, regions gaining 5hmC during early activation (day 1) were highly enriched for variants associated with several autoimmune diseases including Crohn's disease, multiple sclerosis, celiac disease, myasthenia gravis and psoriasis. The effect of these potentially regulatory variants on DNA-protein binding was directly tested in primary human CD4 + Tcells and provides multiple molecular pathways for further investigation. By combining these results with chromatin interaction (capture Hi-C) data from a human T-cell line we found that 5hmC variants are enriched for connections between distal regulatory elements and identify several interactions, which if disrupted by risk variants, may have pathogenic consequences in autoimmune disease. Notably, dynamic 5hmC regions were more enriched for regulatory interactions than cell-type specific enhancers identified by profiling of multiple histone marks (Hawkins et al., 2013) . Combined with the ability to perform 5hmC-profiling on small amounts of archived DNA, this surprising and provocative finding suggests that 5hmC alone may be a powerful and cost-effective approach for prioritization of regulatory variants in humans.
In conclusion, 5hmC-mediated DNA de-methylation plays key roles in the differentiation of human CD4 + T-cells, marking regions relevant for the pathogenesis of several autoimmune diseases and represents a novel, inexpensive and accessible approach for identifying causal disease variants in autoimmune disease.
EXPERIMENTAL PROCEDURES
Ethics Statement
This study was approved by the ethics board of Linkoping University and all participants provided written consent for participation.
Cell Isolation and stimulation
Peripheral blood mononuclear cells (PBMCs) were enriched from healthy donor buffy coats using Lymphoprep (Axis-shield). Human total CD4 + T-cells or Naïve CD4 + T-cells were then isolated through magnetic sorting (Miltenyi Biotec). Naïve T-cells were cultured with plate bound anti-CD3 (500ng/µL) and soluble anti-CD28 (500ng/µL) in the presence of IL-12 (5ng/mL), IL-2 (10ng/mL) and anti-IL4 (5µg/mL) for Th1-or IL-4 (10ng/mL), IL-2 (10ng/mL), anti-IFNG (5µg/mL) and anti-IL12 (5µg/mL) for Th2 conditions. Cells were grown for up to five days in RPMI-1640 medium (Life technologies) supplemented with 2mM Lglutamine (PAA laboratories), 10% heat-inactivated FCS (PAA laboratories) and 50µg/mL gentamicin (Sigma-Aldrich). Cells were re-stimulated with respective condition (see above)
after three days in culture.
DNA and RNA extraction
Total RNA and genomic DNA was extracted using AllPrep DNA/RNA mini kit (Qiagen).
DNA and RNA integrity was determined using a 2100 Bioanalyzer (Agilent).
hMeDIP-Seq and data analysis
DNA (1.5µg) was fragmented by sonication using a Bioruptor (6 x 15min 30s on/off, Diagenode) then subjected to end-repair, dA-tailing, and adaptor-ligation using the NEBNext DNA Library Prep Master Mix Set for Illumina (New England Biolabs). Samples were hydroxymethylated DNA immuno-precipitated (hMeDIP) as previously described (Nestor et al., 2012) . Briefly, DNA was denatured and incubated with 1μg antibody against 5hmC (ActiveMotif; #39769) overnight at 4°C. IP and input DNA was prepared using magnetic beads (Dynabeads Protein G; Invitrogen) and amplified using NEBNext Multiplex Oligos for Illumina (New England Biolabs). Samples were separated by electrophoresis on a 2% low melting point agarose gel and fragments between 100 -400 bp were selected. DNA was purified using the QIAquick Gel Extraction Kit (QIAGEN) and sequenced on an Illumina HiSeq 2000 platform. Reads were mapped to the human genome (hg19) using bowtie with the following parameters (bowtie -v 1 -best -S). Peak calling was performed using MACS with input samples as control.
Immuno dot-blotting
DNA was denatured and applied to a positively charged nylon membrane under vacuum using a Dot Blot Hybridisation Manifold (Harvard Apparatus Limited, UK). The membrane was washed twice in 2X SSC buffer, air-dried and UV-crosslinked. Membranes were incubated with an antibody against 5hmC (1:3000, Active Motif) for 1h at 4°C then washed in TBS-Tween (0.05%) and incubated with a HRP conjugated goat-anti-rabbit antibody (1:10000, Bio-Rad). Following treatment with enhanced chemiluminescence (ECL) substrate, membranes were scanned on a ChemiDoc MP imaging system (Bio-Rad). To control for loading, membranes were stained with methylene blue. Spot intensities were quantified using ImageJ (NIH).
Gene expression microarrays and analysis
For gene expression microarrays, RNA was labeled and amplified using the Low Input Quick Amp Labeling kit (Agilent Technologies), then hybridized onto SurePrint G3 Human Gene Expression 8x60K v2 microarrays (Agilent Technologies) and scanned using a Surescan High Resolution DNA Microarray Scanner (Agilent Technologies). Raw intensities were exported with Agilent's Feature Extraction Software. All subsequent analyses were performed using the LIMMA package in the R statistical programming language. Briefly, data was background corrected and quantile normalized then control probes, probes not expressed (background +10%) in all conditions and non-annotated probes were removed.
Statistical analysis
P-values < 0.05 were considered significant and when stated, p-values were adjusted using Benjamini-Hochberg correction.
Data access
All raw and processed microarray and next-generation sequencing data will be made publically available in the ArrayExpress database. Wu, H., D'Alessio, A.C., Ito, S., Xia, K., Wang, Z., Cui, K., Zhao, K., Sun, Y.E., and Zhang, Y. (2011) . Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 473, 389-393. Wu, H., and Zhang, Y. (2014) . Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell 156, 45-68. Yamane, H., and Paul, W.E. (2013) . Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol Rev 252, 12-23. Yang, R., Qu, C., Zhou, Y., Konkel, J.E., Shi, S., Liu, Y., Chen, C., Liu, S., Liu, D., Chen, Y., et al. (2015) . Hydrogen Sulfide Promotes Tet1-and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis. Immunity 43, 251-263. Yu, M., Hon, G.C., Szulwach, K.E., Song, C.X., Zhang, L., Kim, A., Li, X., Dai, Q., Shen, Y., Park, B., et al. (2012) . Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 149, 1368-1380. 
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